Federal excise taxes on medical device sales have been proposed to help fund health care reform, prompting industry worries the $4 billion in annual fees will stifle innovation and eliminate jobs.It’s a chief concern among Colorado manufacturers — who employ nearly 11,000 people in the state — though they support reform.John Collar, CEO and president of the Colorado BioScience Association (CBSA) trade group, flew to Washington, D.C., at the end of September to tell Sens. Mark Udall and Michael Bennet that the industry sees the fees proposed in Sen. Max Baucus’ leading bill as a potential disaster.
No comments:
Post a Comment